Ignite Creation Date:
2025-12-24 @ 9:47 PM
Ignite Modification Date:
2026-01-01 @ 6:39 PM
Study NCT ID:
NCT05187832
Status:
RECRUITING
Last Update Posted:
2024-02-29
First Post:
2021-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
Sponsor:
Kind Pharmaceuticals LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-05
Start Date Type:
ACTUAL
Primary Completion Date:
2026-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-10
First Submit QC Date:
None
Study First Post Date:
2022-01-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-28
Last Update Post Date:
2024-02-29
Last Update Post Date Type:
ACTUAL